{"SPADE_UN_11715": {"Clinical Information": [], "Patent Information": [], "Sequence Information": {"SPADE ID": "SPADE_UN_11715", "Peptide Name": "[W]9-VmCT1-NH2 VmCT1 petide derivative", "Source": "Synthetic construct", "Family": "Belongs to the scorpion NDBP 11 family", "Gene": "Not found", "Sequence": "FLGALWNVWKSVF", "Sequence Length": 13, "UniProt Entry": "No entry found", "Protein Existence": "Synthetic", "Biological Activity": ["Antimicrobial", "Antibacterial"], "Target Organism": "[Ref.27912176] Gram-negative bacteria:Escherichia coli (SBS 363)(MIC=1.56μmol/L);Pseudomonas aeruginosa (ATCC 27853)(MIC=0.78μmol/L);Escherichia coli (D31)(MIC=1.56μmol/L);Serratia marcescens (ATCC 4112)(MIC=1.56μmol/L);Enterobacter cloacae (beta-12)(MIC=6.52μmol/L);Gram-positive bacteria:Micrococcus luteus (A270)(MIC=1.56μmol/L);Staphylococcus aureus (ATCC 29213)(MIC=6.25μmol/L);Bacillus subtilis (ATCC 6633)(MIC=3.12μmol/L);Staphylococcus epidermidis (ATCC 12228)(MIC=1.56μmol/L);Fungi:Candida albicans MDM8(MIC=6.25μmol/L);Candida tropicalis (IOC 4560)(MIC=50μmol/L);Candida parapsilosis (IOC 4564)(MIC=50μmol/L);Aspergillus niger(MIC=50μmol/L);Cladosporium herbarum (ATCC 26362)(MIC=50μmol/L);Cryptococcus neoformans(MIC=3.12μmol/L)", "Hemolytic Activity": "[Ref.27912176]MHC=1.60μmol/L against human red blood cells", "Cytotoxicity": "No cytotoxicity information found in the reference(s) presented", "Binding Target": "Not found", "Linear/Cyclic": "Linear", "N-terminal Modification": "Free", "C-terminal Modification": "Amidation", "Stereochemistry": "L", "Structure Description": "The peptide adopts Helical fraction 0.02 in water;0.11 in TFE/Water;0.30 in POPC;0.11 in POPC:POPG;0.24 in POPC:DOPE;", "Formula": "C80H111N17O16", "Mass": 1566.84, "PI": 8.75, "Net Charge": 1, "Hydrophobicity": 1.0, "Half Life": "Mammalian:1.1 hourYeast:3 minE.coli:2 min", "Function": "Antibacterial activity against the Gram-positive and Gram-negative bacteria and fungi.It antimicrobial activities are increased or preserved when compared to VmCT1.", "Literature": [{"Title": "Novel designed VmCT1 analogs with increased antimicrobial activity.", "Pubmed ID": "27912176", "Reference": "Eur J Med Chem. 2017 Jan 27;126456-463.", "Author": "Pedron CN, Torres MT, Lima JADS, Silva PI, Silva FD, Oliveira VX.", "URL": "http://www.ncbi.nlm.nih.gov/pubmed/?term=27912176"}, {"Title": "novel designed VmCT1 analogs with increased antimicrobial activity", "Pubmed ID": "", "Author": "Pedron Cn, Torres MT, Lima JA, Silva PI, Silva FD, Oliveira VX"}], "Frequent Amino Acids": "FLV", "Absent Amino Acids": "CDEHIMOPQRTUY", "Basic Residues": 1, "Acidic Residues": 0, "Hydrophobic Residues": 9, "Polar Residues": 6, "Positive Residues": 1, "Negative Residues": 0, "Similar Sequences": [{"SPADE_ID": "SPADE_N_03252", "Similarity": 0.9230769230769231, "Sequence": "FLGALWNVAKSVF"}, {"SPADE_ID": "SPADE_UN_11716", "Similarity": 0.9230769230769231, "Sequence": "FLGELWNVWKSVF"}, {"SPADE_ID": "SPADE_UN_12071", "Similarity": 0.9230769230769231, "Sequence": "FLGALWNVLKSVF"}]}}}